Brentuximab vedotin in advanced-stage mycosis fungoides/Sézary syndrome with low CD30 expression: real-world data from the German Cutaneous Lymphoma Network
Simple SummaryAdvanced-stage mycosis fungoides (MF) and Sézary syndrome (SS) are aggressive cutaneous T-cell lymphomas with limited treatment options ...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
28 December 2025
|
| In: |
Cancers
Year: 2025, Volume: 18, Issue: 1, Pages: 1-12 |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers18010097 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.3390/cancers18010097 Verlag, kostenfrei, Volltext: https://www.mdpi.com/2072-6694/18/1/97 |
| Author Notes: | Christoph Blazejak, Mathias Oymanns, René Stranzenbach, Uwe Hillen, Christina Mitteldorf, Jan P. Nicolay, Marion Wobser, Philipp Schrüfer, Janika Gosmann, Ulrike Wehkamp, Nina Booken, Alexander Kreuter, Edgar Dippel, Claus-Detlev Klemke, Maria Weyermann, Rudolf Stadler and Chalid Assaf |
MARC
| LEADER | 00000naa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1961761157 | ||
| 003 | DE-627 | ||
| 005 | 20260219094330.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 260219s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/cancers18010097 |2 doi | |
| 035 | |a (DE-627)1961761157 | ||
| 035 | |a (DE-599)KXP1961761157 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Blazejak, Christoph |e VerfasserIn |0 (DE-588)1159647313 |0 (DE-627)1022299980 |0 (DE-576)505153947 |4 aut | |
| 245 | 1 | 0 | |a Brentuximab vedotin in advanced-stage mycosis fungoides/Sézary syndrome with low CD30 expression |b real-world data from the German Cutaneous Lymphoma Network |c Christoph Blazejak, Mathias Oymanns, René Stranzenbach, Uwe Hillen, Christina Mitteldorf, Jan P. Nicolay, Marion Wobser, Philipp Schrüfer, Janika Gosmann, Ulrike Wehkamp, Nina Booken, Alexander Kreuter, Edgar Dippel, Claus-Detlev Klemke, Maria Weyermann, Rudolf Stadler and Chalid Assaf |
| 264 | 1 | |c 28 December 2025 | |
| 300 | |b Diagramm | ||
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 19.02.2026 | ||
| 520 | |a Simple SummaryAdvanced-stage mycosis fungoides (MF) and Sézary syndrome (SS) are aggressive cutaneous T-cell lymphomas with limited treatment options ... | ||
| 650 | 4 | |a brentuximab vedotin | |
| 650 | 4 | |a CD30 | |
| 650 | 4 | |a CTCL | |
| 650 | 4 | |a cutaneous T-cell lymphoma | |
| 650 | 4 | |a mycosis fungoides | |
| 650 | 4 | |a Sézary syndrome | |
| 650 | 4 | |a treatment | |
| 700 | 1 | |a Oymanns, Mathias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stranzenbach, René |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hillen, Uwe |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mitteldorf, Christina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nicolay, Jan Peter |d 1981- |e VerfasserIn |0 (DE-588)138614474 |0 (DE-627)604867352 |0 (DE-576)308046188 |4 aut | |
| 700 | 1 | |a Wobser, Marion |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schrüfer, Philipp |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gosmann, Janika |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wehkamp, Ulrike |e VerfasserIn |4 aut | |
| 700 | 1 | |a Booken, Nina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kreuter, Alexander |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dippel, Edgar |e VerfasserIn |4 aut | |
| 700 | 1 | |a Klemke, Claus-Detlev |e VerfasserIn |4 aut | |
| 700 | 1 | |a Weyermann, Maria |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stadler, Rudolf |e VerfasserIn |4 aut | |
| 700 | 1 | |a Assaf, Chalid |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancers |d Basel : MDPI, 2009 |g 18(2025), 1, Artikel-ID 97, Seite 1-12 |h Online-Ressource |w (DE-627)614095670 |w (DE-600)2527080-1 |w (DE-576)313958548 |x 2072-6694 |7 nnas |a Brentuximab vedotin in advanced-stage mycosis fungoides/Sézary syndrome with low CD30 expression real-world data from the German Cutaneous Lymphoma Network |
| 773 | 1 | 8 | |g volume:18 |g year:2025 |g number:1 |g elocationid:97 |g pages:1-12 |g extent:12 |a Brentuximab vedotin in advanced-stage mycosis fungoides/Sézary syndrome with low CD30 expression real-world data from the German Cutaneous Lymphoma Network |
| 856 | 4 | 0 | |u https://doi.org/10.3390/cancers18010097 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |7 0 |
| 856 | 4 | 0 | |u https://www.mdpi.com/2072-6694/18/1/97 |x Verlag |z kostenfrei |3 Volltext |7 0 |
| 951 | |a AR | ||
| 992 | |a 20260219 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 138614474 |a Nicolay, Jan Peter |m 138614474:Nicolay, Jan Peter |d 60000 |d 61900 |e 60000PN138614474 |e 61900PN138614474 |k 0/60000/ |k 1/60000/61900/ |p 6 | ||
| 999 | |a KXP-PPN1961761157 |e 4920221789 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 19.02.2026"],"title":[{"subtitle":"real-world data from the German Cutaneous Lymphoma Network","title":"Brentuximab vedotin in advanced-stage mycosis fungoides/Sézary syndrome with low CD30 expression","title_sort":"Brentuximab vedotin in advanced-stage mycosis fungoides/Sézary syndrome with low CD30 expression"}],"person":[{"family":"Blazejak","role":"aut","given":"Christoph","display":"Blazejak, Christoph"},{"family":"Oymanns","given":"Mathias","role":"aut","display":"Oymanns, Mathias"},{"given":"René","role":"aut","family":"Stranzenbach","display":"Stranzenbach, René"},{"role":"aut","given":"Uwe","family":"Hillen","display":"Hillen, Uwe"},{"family":"Mitteldorf","role":"aut","given":"Christina","display":"Mitteldorf, Christina"},{"role":"aut","given":"Jan Peter","family":"Nicolay","display":"Nicolay, Jan Peter"},{"family":"Wobser","role":"aut","given":"Marion","display":"Wobser, Marion"},{"given":"Philipp","role":"aut","family":"Schrüfer","display":"Schrüfer, Philipp"},{"display":"Gosmann, Janika","given":"Janika","role":"aut","family":"Gosmann"},{"display":"Wehkamp, Ulrike","family":"Wehkamp","role":"aut","given":"Ulrike"},{"family":"Booken","role":"aut","given":"Nina","display":"Booken, Nina"},{"given":"Alexander","role":"aut","family":"Kreuter","display":"Kreuter, Alexander"},{"given":"Edgar","role":"aut","family":"Dippel","display":"Dippel, Edgar"},{"display":"Klemke, Claus-Detlev","given":"Claus-Detlev","role":"aut","family":"Klemke"},{"display":"Weyermann, Maria","role":"aut","given":"Maria","family":"Weyermann"},{"given":"Rudolf","role":"aut","family":"Stadler","display":"Stadler, Rudolf"},{"given":"Chalid","role":"aut","family":"Assaf","display":"Assaf, Chalid"}],"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"28 December 2025"}],"id":{"eki":["1961761157"],"doi":["10.3390/cancers18010097"]},"name":{"displayForm":["Christoph Blazejak, Mathias Oymanns, René Stranzenbach, Uwe Hillen, Christina Mitteldorf, Jan P. Nicolay, Marion Wobser, Philipp Schrüfer, Janika Gosmann, Ulrike Wehkamp, Nina Booken, Alexander Kreuter, Edgar Dippel, Claus-Detlev Klemke, Maria Weyermann, Rudolf Stadler and Chalid Assaf"]},"physDesc":[{"extent":"12 S.","noteIll":"Diagramm"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"note":["Gesehen am 27.05.2020"],"title":[{"title_sort":"Cancers","title":"Cancers"}],"disp":"Brentuximab vedotin in advanced-stage mycosis fungoides/Sézary syndrome with low CD30 expression real-world data from the German Cutaneous Lymphoma NetworkCancers","origin":[{"publisher":"MDPI","dateIssuedDisp":"2009-","publisherPlace":"Basel","dateIssuedKey":"2009"}],"name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]},"recId":"614095670","pubHistory":["1.2009 -"],"part":{"text":"18(2025), 1, Artikel-ID 97, Seite 1-12","year":"2025","issue":"1","pages":"1-12","volume":"18","extent":"12"},"id":{"eki":["614095670"],"issn":["2072-6694"],"zdb":["2527080-1"]}}],"language":["eng"],"recId":"1961761157"} | ||
| SRT | |a BLAZEJAKCHBRENTUXIMA2820 | ||